FindTrial
Sign In

Determination of plasma tigecycline concentration in patients with high cardiac output in septic shock and its application to population pharmacokinetics study

Determination of plasma tigecycline concentration in patients with high cardiac output in septic shock and its application to population pharmacokinetics study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037475
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

septic shock

Interventions

High cardiac output group and low cardiac output group:no

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Patients who need tigecycline in treatment of septic shock; (2) CI>3.5L/min/m2; (3) Sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Unwilling to sign informed consent; (2) Not a septic shock patient; (3) CI<3.5L/min/m2; (4) Tigecycline not used.

Design outcomes

Primary

MeasureTime frame
plasma tigecycline concentration;—

Countries

China

Contacts

Public ContactZhuang Yugang

Shanghai Tenth People's Hospital

zhuangyugang@tongji.edu.cn+86 18917687597

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026